Public Calendar: September 28 - October 4, 2025
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs
Event Date: 09/29/2025
Location: Washington, DC
Subject: Alexandria Real Estate Equities Summit; Speaker: Policies Advancing Health Science Innovation
FDA Participant/Group: GRACE GRAHAM;
Non FDA Participant/Group: Industry, academia, government, biotech, and pharma
Event Date: 10/02/2025
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Senator Bill Cassidy, M.D. (R-LA)
Event Date: 10/03/2025
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Senator Steve Daines (R-MT)
Event Date: 10/03/2025
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representative Christopher Smith (R-NJ)
Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs
Event Date: 09/30/2025
Location: Baltimore, MD
Subject: Society for Clinical Data Management (SCDM) 2025 Annual Conference; Speaker: Keynote Address
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders
Official Name: Sean R. Keveney, Chief Counsel
No Significant Event
Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs
Event Date: 09/29/2025
Location: Washington, DC
Subject: Alexandria Real Estate Equities Summit; Panelist
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, biotech, and pharma
Event Date: 09/30/2025
Location: Washington, DC
Subject: Alliance for Aging Research 2025 Heroes in Health Celebration
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees
Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods
No Significant Event
Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations
No Significant Event
Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives
No Significant Event
Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations
No Significant Event
Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research
No Significant Event
Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: George F. Tidmarsh, M.D., Ph.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products
No Significant Event
Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine
No Significant Event